After a years-long bull market, finding cheap stocks to buy is a daunting task. Luckily, you can still find a variety of companies in the biotech industry with under-appreciated potential.
Investors seeking a well established company with steady profits will want to take a closer look at Gilead Sciences, Inc. (NASDAQ:GILD). Those of you with a heightened sense of adventure might want to focus on tiny Celldex Therapeutics, Inc. (NASDAQ:CLDX) and its clinical-stage cancer drugs. If your appetite for risk lies somewhere between these two, then I suggest a closer look at Omeros Corporation (NASDAQ:OMER).